Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Mohamed T. Abuelazm"'
Autor:
Ahmed Mazen Amin, Ramy Ghaly, Mohamed T. Abuelazm, Ahmed A. Ibrahim, Mohammad Tanashat, Moumen Arnaout, Obieda Altobaishat, Ahmed Elshahat, Basel Abdelazeem, Sudarshan Balla
Publikováno v:
Thrombosis Journal, Vol 22, Iss 1, Pp 1-14 (2024)
Abstract Background Clinical decision support systems (CDSS) have been utilized as a low-cost intervention to improve healthcare process measures. Thus, we aim to estimate CDSS efficacy to optimize adherence to oral anticoagulant guidelines in eligib
Externí odkaz:
https://doaj.org/article/01f3a04b747c4e0293a38e96326eac95
Autor:
Mohamed T. Abuelazm, Abdelrahman Attia, Mohamed Abdelnabi, Uzair Jafar, Omar Almaadawy, Mohamed A. Elzeftawy, Abdelrahman Mahmoud, Khaled Albakri, Basel Abdelazeem
Publikováno v:
The Egyptian Heart Journal, Vol 76, Iss 1, Pp 1-14 (2024)
Abstract Background Soluble guanylate cyclase (sGC) stimulators have been investigated for heart failure (HF) in several randomized controlled trials (RCTs). However, its place in the management guidelines of either HFrEF or HfpEF is still inconclusi
Externí odkaz:
https://doaj.org/article/7b91382894ce43b2877eb91aa1437323
Autor:
Othman Saleh, Mohamed T. Abuelazm, Islam Mohamed, Alaa Ramadan, Mohammad Assaf, Ahmad Alzoubi, Majd M. AlBarakat, Basel Abdelazeem
Publikováno v:
JGH Open, Vol 8, Iss 4, Pp n/a-n/a (2024)
Abstract Background and Aim Etrolizumab is a gut‐targeted anti‐β7 integrin monoclonal antibody. However, the evidence of etrolizumab efficacy and safety in ulcerative colitis remains inconclusive. Therefore, we aim to evaluate the safety and eff
Externí odkaz:
https://doaj.org/article/d0c8b3d12d144ca98b476ddd780bb1a3
Autor:
Mohamed T. Abuelazm, Ahmed Ghanem, Basant E. Katamesh, Abdul Rhman Hassan, Hassan Abdalshafy, Amith Reddy Seri, Ahmed K. Awad, Mohamed Abdelnabi, Basel Abdelazeem
Publikováno v:
Annals of Noninvasive Electrocardiology, Vol 28, Iss 5, Pp n/a-n/a (2023)
Abstract Background and Objective Double sequential external defibrillation (DSED) and vector‐change defibrillation (VCD) have been suggested to enhance clinical outcomes for patients with ventricular fibrillation (VF) refractory of standard defibr
Externí odkaz:
https://doaj.org/article/3b1eb49ef4b248c6bbb676b37c1da45a
Autor:
Basel Abdelazeem, Mohamed T. Abuelazm, Sarya Swed, Mohamed Gamal, Mostafa Atef, Mohamed A. Al‐Zeftawy, Muhammad A. Noori, Anthony Lutz, Annabelle S. Volgman
Publikováno v:
Clinical Cardiology. 45:1171-1183
Radial artery spasm (RAS) is the most common cause of transradial access site crossover and is a common intra-procedural complication. RAS incidence can lead to radial artery occlusion (RAO) postprocedure, preventing the radial artery as a future acc
Autor:
Mohamed T. Abuelazm, Ahmed Ghanem, Amit Johanis, Abdelrahman Mahmoud, Abdul Rhman Hassan, Basant E. Katamesh, Mostafa Atef Amin, Basel Abdelazeem
Publikováno v:
International Urology and Nephrology.
Background and objective There is currently no FDA-approved medical therapy for delayed graft function (DGF). Dexmedetomidine (DEX) has multiple reno-protective effects preventing ischemic reperfusion injury, DGF, and acute kidney injury. Therefore,
Autor:
Mohamed T. Abuelazm, Basel Abdelazeem, Helmy Badr, Mohamed Gamal, Mohamed Ashraf, Sherief Abd‐elsalam
Publikováno v:
Tropical medicineinternational health : TMIHREFERENCES. 27(3)
Lymphatic filariasis is a serious public health issue. Recent studies showed that a single dosage of triple therapy (Ivermectin, Diethylcarbamazepine, and Albendazole) is more effective than dual therapy (Ivermectin plus Albendazole or Diethylcarbama